Shares of Sarepta Therapeutics SRPT have soared 43% year to date, significantly outperforming the industry’s 6.9% decline.

After hours: November 29 at 4:53 PM EST Loading Chart for SRPT ...

Bernstein lowered the firm’s price target on Arrowhead (ARWR) to $24 from $27 and keeps a Market Perform rating on the shares. The company’s ...

Piper Sandler、Chardan Capital Markets和花旗都对这一发展做出了反应。Piper Sandler将Arrowhead的12个月目标价从之前的$62下调至$45，同时维持超配评级。Chardan Capital Markets维持对Arrowhead的买入评级和$60.00的股票目标价。花旗则略微下调目标价，从$27.00降至$26.00，同时保持对该股票的中性立场 ...

After hours: November 27 at 6:14 PM EST Loading Chart for FULC ...